Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-045 - Phase 1/2 Study of BLU-945 in Patients With Common Activating EGFR-Mutant Non-Small Cell Lung Cancer
Author(s): Elaine Shum- Abstract
Loading... -
+
EP08.02-108 - Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
Author(s): Marina Chiara Garassino- Abstract
Loading... -
+
EP08.02-113 - Clinico-genomic Characteristics of Patients with Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
Author(s): Masanobu Okahisa- Abstract
Loading... -
+
EP08.02-115 - A Retrospective, Multicenter, Observational Study to Evaluate Outcomes With Lorlatinib After Alectinib in ALK+ NSCLC in Japan
Author(s): Motohiro Tamiya- Abstract
Loading...
-
+
EP11.01 - Pathology - Genomics & Analytics
- Type: E-Poster
- Track: Pathology - Genomics & Analytics
- Presentations: 12
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP11.01-008 - Discrepancy in MET Exon 14 Skipping Mutation Measurement Between ArcherMET and Oncomine Dx Target Test System
Author(s): Kanako Shinada- Abstract
Loading...
-
+
MA03 - Predicting Outcomes in Patients with Early Disease NSCLC
- Type: Mini Oral
- Track: Early Stage Non-small Cell Lung Cancer
- Presentations: 14
- Moderators:Terufumi Kato
- Coordinates: 8/07/2022, 12:00 - 13:00, Hall C8
-
+
MA03.01 - Session Introduction
12:00 - 12:01 | Author(s): Terufumi Kato
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Author(s): Terufumi Kato
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Author(s): Devayani Niyogi
- Abstract
Loading... -
+
MA03.02 - Session Introduction
12:01 - 12:02 | Author(s): Devayani Niyogi
- Abstract
Loading... -
+
MA03.03 - Predicting Occult Lymph Node Metastasis in Patients With Clinical Stage IA Non-small Cell Lung Cancer: A Prospective Cohort Study
12:02 - 12:07 | Author(s): Junghee Lee
- Abstract
Loading... -
+
MA03.04 - An Integrated Deep Learning Method to Predict Lung Cancer Recurrence Risk for Resected Stage IA NSCLC
12:07 - 12:12 | Author(s): Peng Huang
- Abstract
Loading... -
+
MA03.06 - Discussant
12:17 - 12:27 | Author(s): David Harpole
- Abstract
Loading... -
+
MA03.05 - EGFR mutation Is Not a Risk Factor for Postoperative Recurrence of Lung Adenocarcinoma on Long Follow-up of a Multi-Institutional Cohort
12:12 - 12:17 | Author(s): Yuki Matsumura
- Abstract
Loading... -
+
MA03.06 - Discussant
12:17 - 12:27 | Author(s): Betty Tong
- Abstract
Loading... -
+
MA03.07 - Accurate Intraoperative Diagnosis of Spread Through Air Spaces (STAS) Using a Cryo Embedding Medium Inflation Method
12:27 - 12:32 | Author(s): Takashi Eguchi
- Abstract
Loading... -
+
MA03.08 - Survival Impact of Benchmarking Lung Cancer Surgeons’ Performance by Quality Metrics
12:32 - 12:37 | Author(s): Meredith Ray
- Abstract
Loading... -
+
MA03.09 - Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.
12:37 - 12:42 | Author(s): Peter S.N. van Rossum
- Abstract
Loading... -
+
MA03.10 - Discussant
12:42 - 12:52 | Author(s): Young Tae Kim
- Abstract
Loading... -
+
MA03.11 - Live Q&A
12:52 - 13:00
- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Presentations: 10
- Moderators:Alessandra Curioni-Fontecedro
- Coordinates: 8/08/2022, 16:00 - 17:00, Hall C8
-
+
OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results
16:32 - 16:42 | Author(s): Charles M Rudin
- Abstract
Loading...
